// App-Quantinova.ai

181 : Prevalence of Renal Impairment in a US Rheumatoid Arthritis Population

Researchers

Presenter

  • Lee Simon

Principal Investigators

  • Janet Pope

  • Jim Paik

  • Michael Grabner

  • Amanda Quebe

  • Carol Gaich

  • Claudia Salinas

  • Jeffrey Curtis

Medical Centers

  • Division of Hematology/Oncology, Columbia University, New York, NY

  • SDG LLC, Cambridge, MA

  • Western Univeristy, London, ON, Canada

  • Eli Lilly and Company, Indianapolis, IN

  • HealthCore, Inc., Wilmington, DE

  • Eli Lilly and Company, Indianapolis, IN

  • University of Alabama at Birmingham, Birmingham, AL

Locations

  • United States

  • Canada

Companies

  • Health Core, Inc.

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Nephrology

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Renal insufficiency

  • Inflammatory Arthritis

Biomarkers

  • Creatinine

Drug/Treatment

  • Tasocitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved